Creatine during GLP-1 treatment: trial design.
NCT07625202: a registered trial design, not a treatment result. The estimated enrolment is not the number of participants who completed the trial.
Source snapshot: 2026-08-30. Figure version: 2026-08-30.1.
Table and explanation: https://stemcellatlas.com/en/guides/glp-1-creatine
Figure: https://stemcellatlas.com/en/data/longevity-comparisons#glp-1-creatine-trial
Sources:
https://clinicaltrials.gov/study/NCT07625202
ClinicalTrials.gov NCT07625202: registry update 2026-06-04; retrieved 2026-08-30. Selected fields, shortened labels and editorial comparison; original registry record unchanged.